Chinese Journal of Pharmacovigilance ›› 2018, Vol. 15 ›› Issue (3): 191-192.
MAO Jiao-jiao
Received:
2018-05-04
Revised:
2018-05-04
Online:
2018-03-20
Published:
2018-05-04
CLC Number:
MAO Jiao-jiao . One Case of Hepatic Dysfunction Induced by Sodium Valproate for Injection [J]. Chinese Journal of Pharmacovigilance, 2018, 15(3): 191-192.
[1] 李建生,刘蔚. 药物性肝病发病机制及分类[J]. 中国实用内科杂志,2008,28(3):215-217. [2] 刘艳荣. 头孢呋辛不良反应分析[J]. 浙江临床医学,2017,19(1):130-131. [3] 惠红岩,周祥,陈明,等. 丙戊酸钠致严重急性肝损伤的回顾性分析[J]. 中国药事, 2017,31(7) :819-823. [4] 黄坚彤. 口服丙戊酸钠致黄疸1例[J]. 中国药物警戒,2011,8(9):570-571. [5] Dunner D L. Drug interactions of lithium and other antimanic/ mood-stabilizing medications[J]. J Clin Psychiatry, 2003, 64 (5):38-43. [6] Nanau R M, Neuman M G. Adverse drug reactions induced by valproic acid[J]. Clin Biochem, 2013, 46(15):1323-38. [7] 曾艳,刘立丽,闫素英. 丙戊酸钠血清浓度接近或超过治疗浓度范围上限患者的肝功能、血常规结果分析[J]. 中国药物应用与监测,2013,10(2):66-70. [8] Jaeschke H, Lemasters J J. Apoptosis versus oncotic necrosis in hepatic ischemia/reperfusion injury[J].Gastroenterology, 2003,125(4):1246-1257. [9] 黄静,任熔娜. 抗癫痫药物致肝损伤的研究进展[J]. 实用儿科临床杂志,2007,22(6):465-467. [10] 明雅南,刘晓琳,茅益民. 药物性肝损伤发病机制研究进展[J]. 实用肝脏病杂志, 2014,17(6):657-660. |
[1] | SUN Qiyue, ZHAO Ronghua, GUO Shanshan, BAO Lei, GENG Zihan, LI Shuran, XU Yingli, ZHANG Jingsheng, CUI Xiaolan, SUN Jing. Multiple pharmacological effects of Lingyang Ganmao Oral Liquid [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 127-131. |
[2] | ZHAO Ronghua, SUN Jing, BAO Lei, GENG Zihan, TAO Xiali, ZHANG Jingsheng, PANG Bo, XU Yingli, CAO Shan, LI Shuran, GUO Shanshan, WANG Daohan, CUI Xiaolan. Mechanisms of Gegen Tang granules against viral pneumonia in mice based on immune regulation [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 132-136. |
[3] | BAO Lei, GENG Zihan, LI Shuran, JI Zuen, ZHAO Ronghua, SUN Jing, GUO Shanshan, CUI Xiaolan. The critical role of TRP channels in the progression of viral pneumonia [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 137-140. |
[4] | JIA Jinsheng, LIU Hongliang, WANG Qing, HOU Yongfang, LI Xinling. Evaluation of the relevance of adverse drug reaction based on ERNIE-DPCNN [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 163-166. |
[5] | LI Jiaxin, LIU Huimin, QIAN Wenxiu, MA Ning, SONG Lili, LI Yubo. Nephrotoxic effects and usage of traditional Chinese medicines based on the Traditional Chinese Medicine Systems Toxicology Database [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 173-180. |
[6] | FAN Kaikai, WANG Cong, LIU Hongfeng, WANG Xiyong. Effects of clinical pharmacist interventions on usage of alanyl-glutamine injections in a hospital [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 181-184. |
[7] | ZHANG Jian, FANG Huihua. Applicability of evaluation standards for use of traditional Chinese medicine injections for promoting blood circulation and removing blood stasis [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 185-189. |
[8] | WANG Shan, XIE Bo, LIU Huimin, LI Zhihao. Adverse event signals for celecoxib based on FAERS database [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 190-194. |
[9] | LI Yingfen, HAN Lei. Analysis of 319 cases of adverse drug reaction induced by cerebroprotein hydrolysate for injection [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 195-198. |
[10] | XU Weijia, PENG Qi, HUANG Haiyu, ZHANG Leijiao, XIAO Hua, WU Xue. 285 cases of adverse drug reaction related to new antineoplastic drugs [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 199-203. |
[11] | GUO Qinghua, PENG Xiaoxiao, ZHU Ping, LIU Xilin, YANG Yinghua, CHEN Zhihai. One case of multiple organ dysfunction syndrome caused by amlodipine overdose [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 204-207. |
[12] | FANG Meilin, ZHENG Huimin, WANG Cunze, WANG Ling, RUAN Junshan. One case of generalized myalgia caused by oxaliplatin [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 208-210. |
[13] | LI Na, GUO Jun, GUO Wenjia, LYU Yinyin, LI Caihong, MU Xiangdong. One case of delayed skin allergic reaction caused by asthma treated with omalizumab injection [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 211-212. |
[14] | CAO Guiping, DENG Linlin, ZHU Ganhong, LU Ying, MA Shuang, CHEN Linlin, Liu Lili. One case of severe liver injury caused by Tianma Shouwu tablets [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 216-218. |
[15] | ZHU Ying, SHEN Lu, LI Lan, WU Jianmin, GAO Xiaojie. Adverse reaction monitoring of toothpaste in China under the new regulatory system [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 219-222. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||